/manager/Index ${session.getAttribute("locale")} 5 Phase 2 multicenter study of gantry-based stereotactic radiotherapy boost for intermediate and high risk prostate cancer (PROMETHEUS) /manager/Repository/uon:34741 Tue 03 Sep 2019 18:02:19 AEST ]]> Rectal protection in prostate stereotactic radiotherapy: a retrospective exploratory analysis of two rectal displacement devices /manager/Repository/uon:31943 P = 0.0012). Comparison (2) demonstrated a moderate difference with centre 2 plans producing slightly lower rectal doses (P = 0.013). Comparison (3) further demonstrated that Rectafix returned lower mean doses than SpaceOAR (P < 0.001). Although all dose levels were in favour of Rectafix, in absolute terms differences were small (2.6-9.0%). Conclusions: In well-selected prostate SBRT patients, Rectafix and SpaceOAR RDD's provide approximately equivalent rectal sparing.]]> Mon 23 Sep 2019 12:36:33 AEST ]]> Reduced motion and improved rectal dosimetry through endorectal immobilization for prostate stereotactic body radiotherapy /manager/Repository/uon:37462 Mon 11 Jan 2021 13:56:26 AEDT ]]>